Comparative bioavailability of two oral formulations of bromazepam in healthy volunteers

Arzneimittel-Forschung/Drug Research

Volumn 51, Issue 12, 2001, Pages 955-958

  Lerner, F E ^a   Schere, D ^a   Batafarano, N ^a   Casas, F ^a   Glancszpigel, R ^a  

^a EDyABE Contract Res Organisation   (Argentina)

Author keywords

1,4 Benzodiazepines; Bromazepam, bioavailability, clinical studies; CAS 1812 30 2

Indexed keywords

BROMAZEPAM;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG FORMULATION; FEMALE; FOOD AND DRUG ADMINISTRATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL;

EID: 0035661058     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1300144     Document Type: Article

References (20)

1. Comparative studies on the bioavailability and pharmacokinetics of bromazepam from tablets
2. Bioavailability of bromazepam in man after single oral administration of an oral solution
3. Bromazepam pharmacokinetics: Influence of age, gender, oral contraceptives, cimetidine, and propranolol
4. Metabolites of bromazepam, a benzodiazepine, in the human, dog, rat and mouse
5. Biopharmaceutical and clinical pharmacokinetic profile of bromazepam
6. On the pharmacokinetics of bromazepam in man
7. Methods for measuring benzodiazepines in plasma
8. Validation of liquid chromatographic and gas chromatographic methods. Applications to pharmacokinetics
9. Validation of bioanalytical methods
10. Long-term compliance with antihypertensive therapy: Another facet of chronotherapeutics in hypertension
11. Adherence: A necessity for successful HIV combination therapy
12. The pharmacokinetics of extended-release formulations of calcium antagonists and of amlodipine in subjects with different gastrointestinal transit times
13. The impact of formulation and process changes on in vitro dissolution and the bioequivalence of piroxicam capsules
14. Average parameters in bioavailability studies: An application to slow-release amitriptyline formulation
15. Comparative bioavailability of two setraline tablet formulations in healthy human volunteers after a single oral dose administration
16. Fluconazole bioequivalence study: Quantification by tandem mass spectrometry
17. Clarithromycin bioequivalence study of two oral formulations in healthy human volunteers
18. In vivo bioequivalence guidance
19. Federal Register
20. Current practice of BA-BE requirements for immediate release products in EU